Page breadcrumb nav

VAERS Report 2157185

Case Report Section

Détails du rapport Vaer

Âge: N/A

Genre: Female

Région : Outside US

Patient décédé?
Non
Renseignements sur les vaccins

Nom: COVID19 (COVID19 (PFIZER-BIONTECH))

Type : Coronavirus 2019 vaccine

Fabricant: PFIZER

Lot: unknown


Date de réception du rapport
2022-03-04
Date à laquelle le formulaire est complèté
Date de vaccination
2021-03-20
Date d’apparition
19
Nombre de jours (date d’apparition – date de vaccination)
19
Description de l’événement indésirable

blood pressure high; tachycardia; cardiac discomfort; this is a spontaneous report received from a contactable reporter(s) (other hcp) from the regulatory authority. regulatory number: is-ra-7302 (ra). a 53 year-old female patient received bnt162b2 (comirnaty), administration date 20mar2021 (batch/lot number: unknown) as dose 1, single for covid-19 immunisation. the patient's relevant medical history and concomitant medications were not reported. the following information was reported: hypertension (medically significant) with onset 08apr2021, outcome "recovered" (2021), described as "blood pressure high"; tachycardia (medically significant) with onset 08apr2021, outcome "recovered" (2021), described as "tachycardia"; cardiac discomfort (medically significant) with onset 08apr2021, outcome "recovered" (2021), described as "cardiac discomfort". the patient underwent the following laboratory tests and procedures: blood pressure measurement: 160/90. reporter comment: after first dose of pfizer, patient experienced cardiac discomfort and blood pressure was taken and was elevated (160/90). after second dose, patient experienced tachycardia, symptoms were ongoing for 3 months. went to see a doctor, tachycardia was seen there. it was reported that the patient underwent a heart check and everything was normal. additional information: the onset latency of the events hypertension and cardiac discomfort was reported as 19 days.; reporter's comments: after first dose of pfizer, patient experienced cardiac discomfort and blood pressure was taken and was elevated (160/90). after second dose, patient experienced tachycardia, symptoms were ongoing for 3 months. went to see a doctor, tachycardia was seen there. it was reported that the patient underwent a heart check and everything was normal. sender's comments: linked report(s) : is-pfizer inc-202200304307 same patient/product, different event/dose

Données de laboratoire
test name: blood pressure; result unstructured data: test result:160/90
Liste des symptômes
tachycardia hypertension blood pressure measurement cardiac discomfort
Patient décédé?
Non
Date de décès
N/A
Anomalie congénitale
false
Vaccin administré par :
Other
Vaccin acheté par :
Inconnu
Visite d’un patient à l’urgence?
Non
Patient hospitalisé?
Non
Séjour à l’hôpital
Non
Nombre de jours à l’hôpital
Non spécifié
Invalidité permanente?
Non
Allergies:
na
Maladie actuelle
na